Skip to main content
Top
Published in: Clinical Rheumatology 12/2007

01-12-2007 | Case Report

Major flares in women with SLE on combined oral contraception

Authors: D. A. Whitelaw, S. J. Jessop

Published in: Clinical Rheumatology | Issue 12/2007

Login to get access

Abstract

Two recent trials concluded that the use of oral contraceptives (OC) did not induce flares in lupus patients. We record our experience with OC in patients with stable lupus. Eight patients were enrolled in an open trial. Six received a combined contraceptive pill and two were allocated to the control arm. During a 12 month follow-up, 3 patients in the active arm experienced 4 major flares. One patient died as a result of uncontrolled disease complicated by sepsis. At this point, we abandoned the trial. The 2 patients in the control arm experienced no disease exacerbation during the 7 months of observation. We would urge that patients who are placed on OC be closely monitored.
Literature
1.
go back to reference Petri M, Kim MY, Kalunian KC et al (2005) Combined oral contraception in women with systemic lupus erythematosus. N Engl J Med 353:2550–2558CrossRefPubMed Petri M, Kim MY, Kalunian KC et al (2005) Combined oral contraception in women with systemic lupus erythematosus. N Engl J Med 353:2550–2558CrossRefPubMed
2.
go back to reference Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L et al (2005) A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 353:2539–2549CrossRefPubMed Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L et al (2005) A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 353:2539–2549CrossRefPubMed
3.
go back to reference Bermas BL (2005) Oral contraceptives in systemic lupus erythematosus—a tough pill to swallow? N Engl J Med 353:2602–2604CrossRefPubMed Bermas BL (2005) Oral contraceptives in systemic lupus erythematosus—a tough pill to swallow? N Engl J Med 353:2602–2604CrossRefPubMed
4.
go back to reference Cooper GS, Parks CG, Treadwell EL et al (2002) Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 11:161–167CrossRefPubMed Cooper GS, Parks CG, Treadwell EL et al (2002) Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 11:161–167CrossRefPubMed
5.
go back to reference Alarcon GS, McGwin G Jr, Petri M et al (2002) Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11:95–101CrossRefPubMed Alarcon GS, McGwin G Jr, Petri M et al (2002) Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11:95–101CrossRefPubMed
6.
go back to reference Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed
7.
go back to reference Austin HA 3rd, Klippel JH, Balow JE et al (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614–619CrossRefPubMed Austin HA 3rd, Klippel JH, Balow JE et al (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614–619CrossRefPubMed
8.
go back to reference Ehrenstein MR, Conroy SE, Heath J et al (1995) The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: a rheumatological view. Br J Rheumatol 34:257–260CrossRefPubMed Ehrenstein MR, Conroy SE, Heath J et al (1995) The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: a rheumatological view. Br J Rheumatol 34:257–260CrossRefPubMed
9.
go back to reference Petri M, Genovese M, Engle E et al (1991) Definition, incidence and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 34:937–944CrossRefPubMed Petri M, Genovese M, Engle E et al (1991) Definition, incidence and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 34:937–944CrossRefPubMed
10.
go back to reference Rampone A, Rampone B, Tirabasso S et al (2001) Contraception with the latest estroprostagens in women suffering from systemic lupus erythematosus. Minerva Ginecol 53(1 Suppl 1):75–77PubMed Rampone A, Rampone B, Tirabasso S et al (2001) Contraception with the latest estroprostagens in women suffering from systemic lupus erythematosus. Minerva Ginecol 53(1 Suppl 1):75–77PubMed
11.
go back to reference Julkunen HA (1991) Oral contraception in systemic lupus erythematosus: side-effects and influence on the activity of SLE. Scand J Rheum 20:427–433CrossRefPubMed Julkunen HA (1991) Oral contraception in systemic lupus erythematosus: side-effects and influence on the activity of SLE. Scand J Rheum 20:427–433CrossRefPubMed
12.
go back to reference Jungers P, Dougados M, Pelissier C et al (1982) Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 25:618–623CrossRefPubMed Jungers P, Dougados M, Pelissier C et al (1982) Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 25:618–623CrossRefPubMed
13.
go back to reference Buyon JP, Petri MA, Kim MY et al (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142:953–962CrossRefPubMed Buyon JP, Petri MA, Kim MY et al (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142:953–962CrossRefPubMed
14.
go back to reference Grimaldi CM, Hill L, Xu X et al (2005) Hormonal modulation of B cell development and repertoire selection. Mol Immunol 42:811–820CrossRefPubMed Grimaldi CM, Hill L, Xu X et al (2005) Hormonal modulation of B cell development and repertoire selection. Mol Immunol 42:811–820CrossRefPubMed
15.
go back to reference Cutolo M (2004) Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 31:419–421PubMed Cutolo M (2004) Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 31:419–421PubMed
Metadata
Title
Major flares in women with SLE on combined oral contraception
Authors
D. A. Whitelaw
S. J. Jessop
Publication date
01-12-2007
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0641-y

Other articles of this Issue 12/2007

Clinical Rheumatology 12/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.